admin

On 30th September, NHS England/Improvement issued a letter entitled “Roadmap for NHS suppliers to reach net zero by 2045” to suppliers in the UK. This letter should not have been a surprise for any supplier, as the commitment to Net Zero was made a year ago and there has been significant activity and discussion across the healthcare industry, including featuring…

A new partner has been announced as part of the Innovative Licensing and Access Pathway (ILAP). The ILAP will be joined by All Wales Therapeutics and Toxicology Centre (AWTTC) as an established partner. The other partners include: Medicines and Healthcare products Regulatory Agency (MHRA), the National Institute for Health and Care Excellence (NICE) and the Scottish Medicines Consortium (SMC). The…

A wide-ranging health and care leadership review has been announced by the Government, which aims to “drive up efficiency and improve outcomes”. The process will be led by retired vice chief of the defence staff general Sir Gordon Messenger, who led last year's mass community Covid-19 testing project in Liverpool and has provided advice to the Government on its planning…

Health and Care Secretary Sajid Javid made his keynote speech at the Conservative Party Conference in Manchester on Tuesday. He made points on a range of issues, covering COVID-19, the NHS’s recovery and healthcare reform. Mr Javid stated that healthcare “begins at home”, with people encouraged to rely on their family first, before the state regarding their health upkeep. Mr…

The Director of Procurement Transformation and Commercial Delivery at NHS England & Improvement has published a 'Roadmap for NHS Suppliers to reach net zero by 2045'. This forms part of the NHS sustainability programme and is an important text that sheds light on how NHS suppliers are to meet the environmental and sustainability standards the NHS expects from its supply…

Virtual conference on Europe’s Beating Cancer Plan from EUCOPE/ BPI The conference will feature two panels, that include high-level experts including stakeholders from industry, patients’ associations and clinicians along with key decisionmakers from the EU institutions. The first panel will focus on how the cancer plan will help make advanced diagnostics available to more cancer patients in Europe, while the second…